134 related articles for article (PubMed ID: 302386)
1. [Role of T and B-lymphocytes in macrophage migration inhibition in mice with methylcholanthrene-induced sarcoma].
Galussio JC; Fridman JL; Tessler J
Medicina (B Aires); 1977; 37(3):264-70. PubMed ID: 302386
[No Abstract] [Full Text] [Related]
2. Incorporation of 125-I-iododeoxyuridine into target cells as an assay for cell immunity.
Fish F; Yaakubovicz M; Witz IP
J Natl Cancer Inst; 1974 Dec; 53(6):1743-7. PubMed ID: 4436870
[No Abstract] [Full Text] [Related]
3. [Effect of different doses of cyclophosphamide on the immune response of mice with a methylcholanthrene-induced sarcoma].
Gordienko SP; Bergol'ts VM
Vopr Onkol; 1973; 19(11):54-60. PubMed ID: 4785975
[No Abstract] [Full Text] [Related]
4. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
Jurin M; Suit HD
Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
[No Abstract] [Full Text] [Related]
5. Cellular immunity to solubilized tumor antigens of a methylcholanthrene-induced sarcoma with a migration inhibition assay.
Padarathsingh ML; Dean JH; McCoy JL; Lewis DD; Northing JW; Natori T; Law LW
J Immunol; 1978 Jun; 120(6):1981-5. PubMed ID: 659888
[TBL] [Abstract][Full Text] [Related]
6. Immunity to murine sarcoma virus-inducted tumors. I. Specific T lymphocytes active in macrophage migration inhibition and lymphocyte transformation.
Gorczynski RM
J Immunol; 1974 May; 112(5):1815-25. PubMed ID: 4361977
[No Abstract] [Full Text] [Related]
7. Macrophage migration inhibition-activity after implantation of methylcholanthrene-induced sarcoma, Ehrlich ascites cancer or mouse ascites hepatoma-134 cancer cells in mice.
Yumura M
Acta Med Okayama; 1976 Feb; 30(1):37-48. PubMed ID: 184687
[TBL] [Abstract][Full Text] [Related]
8. [Effect of the rhythm of cyclophosphamide administration on its antitumor action and on the immune response of mice with methylcholanthrene-induced sarcoma].
Gordienko SP; Bergol'ts VM; Botsmanov KV
Biull Eksp Biol Med; 1974 Jul; 78(7):87-90. PubMed ID: 4451721
[No Abstract] [Full Text] [Related]
9. The effects of tumor bearing upon changes in cell distribution and membrane antigen characteristics in murine spleen and thymus cell subpopulations.
Konda S; Smith RT
Cancer Res; 1973 Aug; 33(8):1878-84. PubMed ID: 4541721
[No Abstract] [Full Text] [Related]
10. Host immunity to a growing transplanted methylcholanthrene-induced guinea pig sarcoma.
Cohen AM; Millar RC; Ketcham AS
Cancer Res; 1972 Nov; 32(11):2421-6. PubMed ID: 5082590
[No Abstract] [Full Text] [Related]
11. Role of different T cells sets in the rejection of syngeneic chemically induced tumors.
Shimizu K; Shen FW
J Immunol; 1979 Mar; 122(3):1162-5. PubMed ID: 312820
[No Abstract] [Full Text] [Related]
12. Clinical applications of in vitro tests for cell-mediated immunity in liver diseases.
Paronetto F; Vernace SJ; Colombo M
Minerva Gastroenterol; 1976; 22(3):227-32. PubMed ID: 1087385
[No Abstract] [Full Text] [Related]
13. Cell-mediated cytotoxicity of adherent and non-adherent mouse lymph node cells sensitized in vitro against tumour-associated antigens of syngenetic methylcholanthrene-induced sarcomas.
Indrová M; Bubeník J
Folia Biol (Praha); 1979; 25(2):137-41. PubMed ID: 456694
[TBL] [Abstract][Full Text] [Related]
14. Use of covalently bound cord factor analog to increase tumor immunogenicity.
Eggers AE; Tarmin L; Ginsburg S
J Biol Response Mod; 1984 Aug; 3(4):413-22. PubMed ID: 6332882
[TBL] [Abstract][Full Text] [Related]
15. Immunity to tumours of the murine leukaemia-sarcoma virus complex.
Owen JJ; Seeger RC
Br J Cancer Suppl; 1973 Aug; 1():26-34. PubMed ID: 4374230
[TBL] [Abstract][Full Text] [Related]
16. In vitro immunization against tumour-associated antigen of methylcholanthrene-induced sarcoma.
Indrová M; Bubeník J
Folia Biol (Praha); 1978; 24(2):118-27. PubMed ID: 658547
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated allograft responses in vitro. VI. Studies on macrophage-mediated cytotoxicity.
Pfizenmaier K; Trostmann H; Röllinghoff M; Wagner H
Immunology; 1975 Dec; 29(6):967-76. PubMed ID: 1081494
[TBL] [Abstract][Full Text] [Related]
18. Nature, function and distribution of inflammatory cells in regressing and progressing Moloney sarcomas.
Russell SW; Gillespie GY
J Reticuloendothel Soc; 1977 Aug; 22(2):159-68. PubMed ID: 72153
[No Abstract] [Full Text] [Related]
19. Thymocytolytic autoantibodies elicited by immunization of mice with chemically-induced sarcoma and leukemia cells.
Merino F
Acta Cient Venez; 1982; 33(5):402-5. PubMed ID: 6985343
[No Abstract] [Full Text] [Related]
20. Discussion paper: in vitro augmentation of tumor immunity in a murine methylcholanthrene sarcoma system.
Yarlott MA; McKhann CF
Ann N Y Acad Sci; 1976; 277(00):533-40. PubMed ID: 187102
[No Abstract] [Full Text] [Related]
[Next] [New Search]
